Role of c-Kit and erythropoietin receptor in erythropoiesis

被引:94
|
作者
Munugalavadla, V [1 ]
Kapur, R [1 ]
机构
[1] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA
关键词
c-kit; SCF; Epo; Epo-R; signal transduction;
D O I
10.1016/j.critrevonc.2004.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Erythropoiesis is regulated by a number of growth factors, among which stem cell factor (SCF) and erythropoietin (Epo) play a nonredundant function. Viable mice with mutations in the SCF gene (encoded by the Steel (Sl) locus), or its receptor gene c-Kit (encoded by the White spotting (W) locus) develop a hypoplastic macrocytic anemia. Mutants of W or Sl that are completely devoid of c-Kit or SCIF expression die in utero of anemia between days 14 and 16 of gestation and contain reduced numbers of erythroid progenitors in the fetal liver. Likewise, Epo and Epo receptor (Epo-R)-deficient mice die in utero due to a marked reduction in the number of committed fetal liver derived erythroid progenitors. Thus, committed erythroid progenitors require both c-Kit and Epo-R signal transduction pathways for their survival, proliferation and differentiation. In vitro, Epo alone is capable of generating mature erythroid progenitors; however, a combined treatment of Epo and SCF results in synergistic proliferation and expansion of developing erythroid progenitors. This review summarizes recent advances made towards understanding the signaling mechanisms by which Epo-R and c-Kit regulate growth, survival, and differentiation of erythroid progenitors alone and cooperatively. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:63 / 75
页数:13
相关论文
共 50 条
  • [21] c-Kit - A hematopoietic cell essential receptor tyrosine kinase
    Edling, Charlotte E.
    Hallberg, Bengt
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (11) : 1995 - 1998
  • [22] The biology of stem cell factor and its receptor C-kit
    Ashman, LK
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) : 1037 - 1051
  • [23] The use of recombinant SCF protein for rapid determination of c-kit expression in normal and abnormal erythropoiesis
    McGuckin, CP
    Uhr, MR
    Liu, WM
    GordonSmith, EC
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 (01) : 72 - 78
  • [24] Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
    Babaei, Maryam Abbaspour
    Kamalidehghan, Behnam
    Saleem, Mohammad
    Huri, Hasniza Zaman
    Ahmadipour, Fatemeh
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2443 - 2459
  • [25] Transcription factor SCL is required for c-kit expression and c-kit function in hemopoietic cells
    Krosl, G
    He, G
    Lefrancois, M
    Charron, F
    Roméo, PH
    Jolicoeur, P
    Kirsch, IR
    Nemer, M
    Hoang, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) : 439 - 450
  • [26] Gene of the month: C-KIT
    Kumari, Niraj
    Lingaiah, Raghavendra
    INDIAN JOURNAL OF CANCER, 2024, 61 (03) : 421 - 425
  • [27] Necrotizing enterocolitis and C-KIT
    Yamataka, A
    Yamataka, T
    Lane, GJ
    Kobayashi, H
    Sueyoshi, N
    Miyano, T
    JOURNAL OF PEDIATRIC SURGERY, 1998, 33 (11) : 1682 - 1685
  • [28] Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome
    Chai, Yuna
    Huang, Yusheng
    Tang, Hongmei
    Tu, Xing
    He, Jianbo
    Wang, Ting
    Zhang, Qingye
    Xiong, Fen
    Li, Detang
    Qiu, Zhenwen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (04) : 1187 - 1193
  • [29] PLZF-mediated control on c-kit expression in CD34+ cells and early erythropoiesis
    I Spinello
    M T Quaranta
    L Pasquini
    E Pelosi
    E Petrucci
    A Pagliuca
    G Castelli
    G Mariani
    D Diverio
    R Foà
    U Testa
    C Labbaye
    Oncogene, 2009, 28 : 2276 - 2288
  • [30] Patent landscape of platelet growth factor receptor and c-KIT targets
    Zhang, Hai-Long
    Kong, Qian
    PHARMACEUTICAL PATENT ANALYST, 2023, 12 (04) : 193 - 204